Sign in

CIK 0001404281

  • Non-accelerated filer
  • Smaller reporting company

Eledon Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-238-8090
Business address
19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
Former names
Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-10 Katkin Keith Director Exercise or conversion +8,575 8,575
2026-01-10 Katkin Keith Director Exercise or conversion · Restricted Stock Units −8,575 0
2025-01-10 Katkin Keith Director Grant or award · Stock Option (right to buy) +77,175 77,175
2025-01-10 Katkin Keith Director Grant or award · Restricted Stock Units +8,575 8,575
2023-05-01 Katkin Keith Director Grant or award · Stock Option (right to buy) +752,185 752,185
2023-02-01 Katkin Keith Director Grant or award · Stock Option (right to buy) +20,000 20,000
2022-02-01 Katkin Keith Director Grant or award · Stock Option (right to buy) +20,000 20,000
2020-09-11 Katkin Keith Director Grant or award · Stock Option (Right to Buy) +5,907.15 5,907.15
2019-07-11 Katkin Keith Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2018-06-13 Katkin Keith Director Grant or award · Stock Option (Right to Buy) +9,100 9,100
2017-06-30 Katkin Keith Director Grant or award · Stock Option (Right to Buy) +36,000 36,000

Page 1 of 1 · 11 trades